The LZTR1 gene helps control how cells grow and divide by keeping certain growth signals in check. This gene plays an important role in keeping those signals balanced, so if it does not work properly, cells may receive growth messages for too long or in the wrong way. Pathogenic variants in the LZTR1 gene can cause Noonan syndrome, which may affect growth, facial features, and the heart. Some variants are also linked to schwannomatosis, a condition with multiple growths along nerves that can cause pain.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes contain the directions for producing proteins, the parts of cells that do the work. Other genes mainly help determine when, where, and how strongly certain processes take place. Together, genes affect how your body develops and works, and they can shape how you respond to food, stress, or medications. For a closer look at this topic, you can learn more in the LearnHub.
Overview
LZTR1Gene function
What if the gene works
The LZTR1 gene helps cells control growth signals, especially the RAS pathway. Its protein tags certain signaling proteins for removal, which helps keep cell communication balanced.
Risk
What if the gene does not work
Variants in the LZTR1 gene can lead to schwannomatosis with nerve sheath tumors and pain, or Noonan syndrome with variable growth, heart, facial, and learning features. Milder and more severe variants can influence which features appear.
Treatment
What does that mean for your treatment
No LZTR1-specific treatment or drug choice is currently established in clinical guidelines. Care is based on your symptoms and the standard treatment plan for the related condition. The LZTR1 gene is being studied as a tumor suppressor and possible biomarker in some cancers.
Conditions associated with LZTR1
Gene function
What if the gene works
A central part of the LZTR1 gene's function is keeping growth messages in balance inside your cells. It helps manage RAS proteins, which pass signals that guide cell growth, division, and routine maintenance. When this system works properly, cells respond to everyday cues in a measured, orderly way.
The LZTR1 gene helps control RAS signaling, a key message system that tells cells when to grow, divide, or pause. When it works properly, these messages stay balanced and appropriately timed.
LZTR1 helps add small tags to selected proteins so cells can adjust their activity and turnover. This tagging system is part of how healthy cells fine tune everyday signaling.
The LZTR1 gene also helps control where certain signaling proteins sit inside the cell, especially near membranes where messages begin. Proper placement helps those signals start and stop in an orderly way.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LZTR1 gene can alter the protein’s shape, shorten it, or make it less stable, so it cannot bind its usual signaling partners as well and cell growth signals become less controlled. Milder variants may partly reduce activity, while more severe variants can remove activity almost completely. This range helps explain how LZTR1 gene variants affect cell signaling and, in conditions linked to the LZTR1 gene, may influence which features appear and how strongly.
How variants are linked to conditions
Pathogenic variants in the LZTR1 gene can cause schwannomatosis, a condition linked to multiple nerve sheath tumors and ongoing pain. Other disease-causing changes in the LZTR1 gene can cause Noonan syndrome, which may affect growth, appearance, and sometimes the heart. In medical genetics, LZTR1 gene variants linked to schwannomatosis and Noonan syndrome are the main well-established condition associations. Not every LZTR1 variant found on testing is harmful.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the LZTR1 gene. For many living with a harmful LZTR1 change, risk is shaped mainly by the variant itself and family history, rather than clear lifestyle factors, and a doctor or genetic counselor can help explain personal risk.
Inheritance of LZTR1 variants
The inheritance pattern for LZTR1-related conditions can differ depending on the specific condition and variant type. Variants in the LZTR1 gene linked to schwannomatosis are usually inherited in an autosomal dominant way, which means a child can inherit the variant from one parent. LZTR1-related Noonan syndrome can also be autosomal dominant, and in some families it follows an autosomal recessive pattern, meaning a child inherits one altered copy from each parent. This mixed picture is why how LZTR1 variants are inherited depends on the diagnosis being considered.
What does my LZTR1 result mean for my family?
For LZTR1, what this means for relatives depends on which condition the result is linked to. Some LZTR1 changes are tied to conditions that can run in families in a dominant way, so close relatives may also carry the same change, while others are linked to a recessive pattern, where parents may be healthy carriers. Because LZTR1 is connected to more than one well-known inherited condition, family implications are best understood in the context of the exact result.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the LZTR1 gene, clinicians use LZTR1 genetic testing on a blood sample or saliva sample. The lab reads the gene, often as part of a multigene panel or exome test, and checks for variants that may help explain a diagnosed condition or a family history.
When should I consider getting a genetic test?
Consider testing for the LZTR1 gene if you or close relatives have had several schwannomas, which are usually noncancerous tumors growing on nerves, or have been diagnosed with schwannomatosis. It may also be considered in some children or adults with features of Noonan syndrome.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, yet how informative they are depends on the specific condition and the kind of variant found. Over time, the way the body functions is also shaped by many other factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes most sense when considered with the rest of a person’s care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than for another. This kind of variation is common and can influence how much benefit a medicine provides or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect the way people respond to medications. It looks at links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more personalized. You can read more about this topic in the LearnHub.
Drugs influenced by the LZTR1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so questions about side effects, unusual reactions, or whether a treatment is right for you are best discussed with your doctor or pharmacist.
History
The LZTR1 gene entered medical research in the late 1990s, when scientists were closely studying the chromosome 22q11.2 region because of its role in inherited conditions. Building on this early work, scientists uncovered more about the gene as genetic testing improved and family studies became more precise. In the 2010s, variants in the LZTR1 gene were linked to schwannomatosis, helping explain why some families developed multiple nerve sheath tumors. Soon after, other studies showed that variants in the same gene could also be involved in Noonan syndrome. That shift made the LZTR1 gene an important example of how one gene can be tied to more than one condition, depending on the specific variant.